Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-058536
Filing Date
2010-03-16
Accepted
2010-03-16 17:06:29
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 969098
2 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 2307
3 CONSENT OF MARCUM LLP dex231.htm EX-23.1 2237
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6212
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6316
6 SECTION 1350 CERTIFICATION dex32.htm EX-32 3667
7 GRAPHIC g75085g45k39.jpg GRAPHIC 34914
  Complete submission text file 0001193125-10-058536.txt   1039843
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33635 | Film No.: 10686272
SIC: 2836 Biological Products, (No Diagnostic Substances)